Histamine H3 receptor-mediated signaling protects mice from cerebral malaria

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Beghdadi, Walid ^a   Porcherie, Adeline ^a   Schneider, Bradley S ^a   Morisset, Séverine ^b   Dubayle, David ^c   Peronet, Roger ^a   Dy, Michel ^d   Louis, Jacques ^a   Arrang, Jean Michel ^b   Mécheri, Salaheddine ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLHISTAMINE; CIMETIDINE; GAMMA INTERFERON; HISTAMINE H3 RECEPTOR; INTERLEUKIN 10; LEVOCETIRIZINE; TELE METHYLHISTAMINE; TUMOR NECROSIS FACTOR ALPHA; HISTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MALARIA; BRAIN PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTAMINE METABOLISM; INFECTION RISK; INFLAMMATORY INFILTRATE; METABOLITE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK REDUCTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; BRAIN; C57BL MOUSE; DISEASE COURSE; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; MALARIA; METABOLISM; PARASITOLOGY; PLASMODIUM BERGHEI; TRANSGENIC MOUSE;

MURINAE; MUS; PLASMODIUM BERGHEI;

ANIMALS; BRAIN; DISEASE PROGRESSION; FEMALE; HISTAMINE; IMMUNE SYSTEM; INFLAMMATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PLASMODIUM BERGHEI; RECEPTORS, HISTAMINE H3; SIGNAL TRANSDUCTION;

EID: 67650302269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006004     Document Type: Article

References (55)

1. Ring J (1985) Histamine and allergic diseases, In new trends in allergy Berlin, Germany: Springer-Verlag press. pp 44-77.
2. Zhang M, Leurs R, Timmerman H (1997) Histamine H1-receptor antagonists. New york, USA. pp 495-559.
3. Schwartz JC, Haas H (1992) The histamine receptor. New york: Wiley Liss.
4. Hill SJ (1990) Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 42: 45-83.
5. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71: 1-51.
6. Tohyama M, Takatsuji K (1998) Atlas of neuroactive substances and their receptors in the rat. Oxford, United Kingdom. pp 54-63.
7. Leurs R, Smit MJ, Timmerman H (1995) Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 66: 413-463.
8. Bury TB, Corhay JL, Radermecker MF (1992) Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 47: 624-629.
9. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, et al. (1998) Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 161: 2586-2593.
10. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, et al. (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59: 434-441.
11. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275: 36781-36786.
12. Morse KL, Behan J, Laz TM, West RE Jr, Greenfeder SA, et al. (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296: 1058-1066.
13. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305: 1212-1221.
14. Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, et al. (2002) Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J Pharmacol Exp Ther 303: 300-307.
15. Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, et al. (2007) Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 178: 8081-8089.
16. Pillot C, Héron A, Cochois V, Tardivel-Lacombe J, Ligneau X, et al. (2002) A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain. Neuroscience 114: 173-193.
17. Schwartz JC, Arrang JM (2002) Histamine. In: Neuropsychopharmacology: The Fifth Generation of Progress. Davis KL, et al., eds. Philadelphia: Lippincott Williams & Wilkins. pp 179-190.
18. Schlicker E, Malinowska B, Kathmann M, Gothert M (1994) Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam Clin Pharmacol 8: 128-137.
19. Bertaccini G, Coruzzi G, Poli E (1991) The histamine H3-receptor: a novel prejunctional receptor regulating gastrointestinal function. Aliment Pharmacol Ther 5: 585-591.
20. Lin JS, Sakai K, Vanni-Mercier G, Arrang JM, Garbarg M, et al. (2000) Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Medicine Reviews 4: 471-503.
21. Clapham J, Kilpatrick GJ (1994) Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 259: 107-114.
22. Tokita S, Takahashi K, Kotani H (2006) Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. J Pharmacol Sci 101: 12-18.
23. Passani MB, Lin JS, Hancock A, Crochet S, Blandina P (2004) The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25: 618-625.
24. Orr EL, Stanley NC (1989) Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis. J Neurochem 53: 111-118.
25. Stanley NC, Jackson FL, Orr EL (1990) Attenuation of experimental autoimmune encephalomyelitis by Compound 48/80 in Lewis rats. J Neuroimmunol 29: 223-228.
26. Ichigi J (1999) Histamine release from mast cells of EAE rats by Gi protein-dependent and IgE-dependent pathways. J Mol Neurosci 13: 93-99.
27. Bhattacharya U, Roy S, Kar PK, Sarangi B, Lahiri SC (1988) Histamine & kinin system in experimental malaria. Indian J Med Res 88: 558-563.
28. Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, et al. (2008) Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J Exp Med 205: 395-408.
29. Belnoue E, Costa FT, Vigario AM, Voza T, Gonnet F, et al. (2003) Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun 71: 3648-3651.
30. Mackey LJ, Hochmann A, June CH, Contreras CE, Lambert PH (1980) Immunopathological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and other tissue lesions during the infection. Clin Exp Immunol 42: 412-420.
31. Kaul DK, Liu XD, Nagel RL, Shear HL (1998) Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria. Am J Trop Med Hyg 58: 240-247.
32. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, et al. (2008) Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29: 306-317.
33. Enwonwu CO, Afolabi BM, Salako LO, Idigbe EO, Bashirelah N (2000) Increased plasma levels of histidine and histamine in falciparum malaria: relevance to severity of infection. J Neural Transm 107: 1273-1287.
34. Nie CQ, Bernard NJ, Schofield L, Hansen DS (2007) CD4 CD25 Regulatory T Cells Suppress CD4T-Cell Function and Inhibit the Development of Plasmodium berghei-Specific TH1 Responses Involved in Cerebral Malaria Pathogenesis. Infection and Immunity 75: 2275-2282.
35. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 22: 503-508.
36. Herwig A, Ivanova EA, Lydon H, Barrett P, Steinlechner S, et al. (2007) Histamine H3 receptor and orexin A expression during daily torpor in the Djungarian hamster (Phodopus sungorus). J Neuroendocrinol 19: 1001-1007.
37. Barone FC, Feuerstein GZ, White RF (1997) Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci Biobehav Rev 21: 31-44.
38. Theodorsson A, Holm L, Theodorsson E (2008) Hypothermia-induced increase in galanin concentrations and ischemic neuroprotection in the rat brain. Neuropeptides 42: 79-87.
39. Airaksinen MS, Alanen S, Szabat E, Visser TJ, Panula P (1992) Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol 323: 103-116.
40. Arrang JM, Gulat-Marnay C, Defontaine N, Schwartz JC (1991) Regulation of histamine release in rat hypothalamus and hippocampus by presynaptic galanin receptors. Peptides 12: 1113-1117.
41. Stevens DR, Eriksson KS, Brown RE, Haas HL (2001) The mechanism of spontaneous firing in histamine neurons. Behav Brain Res 124: 105-112.
42. Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, et al. (2002) On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 169: 6369-6375.
43. Grau GE, Morrow D, Izui S, Lambert PH (1986) Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia. J Immunol 136: 686-691.
44. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC (1996) Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 157: 1620-1624.
45. Senaldi G, Vesin C, Chang R, Grau G, Piguet PF (1994) Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun 62: 1144-1149.
46. Chen L, Zhang Z, Sendo F (2000) Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria. Clin Exp Immunol 120: 125-133.
47. Pais TF, Chatterjee S (2005) Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation. J Neuroimmunol 163: 73-83.
48. Teuscher C, Subramanian M, Noubade R, Gao JF, Offner H, et al. (2007) Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc Natl Acad Sci U S A 104: 10146-10151.
49. Chong CR, Chen X, Shi L, Liu JO, Sullivan DJ Jr. (2006) A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2: 415-416.
50. Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, et al. (2002) Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol 62: 389-397.
51. Ishino T, Orito Y, Chinzei Y, Yuda M (2006) A calcium-dependent protein kinase regulates Plasmodium ookinete access to the midgut epithelial cell. Mol Microbiol 59: 1175-1184.
52. Demeure CE, Brahimi K, Hacini F, Marchand F, Peronet R, et al. (2005) Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol 174: 3932-3940.
53. Serviere J, Dubayle D, Menetrey D (2003) Increase of rat medial habenular mast cell numbers by systemic administration of cyclophosphamide. Toxicol Lett 145: 143-152.
54. Schneider BS, Soong L, Zeidner NS, Higgs S (2004) Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection. Viral Immunol 17: 565-573.
55. Garbarg M, Pollard H, Trung Tuong MD, Schwartz JC, Gros C (1989) Sensitive radioimmunoassays for histamine and tele-methylhistamine in the brain. J Neurochem 53: 1724-1730.